{
    "organizations": [],
    "uuid": "656015518776df055b6d4e64da9bc1121a2b3dd6",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fate-therapeutics-qtrly-loss-per-s/brief-fate-therapeutics-qtrly-loss-per-share-0-27-idUSASC0A1IV",
    "ord_in_thread": 0,
    "title": "BRIEF-Fate Therapeutics Qtrly Loss Per Share $0.27",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Fate Therapeutics Inc:\n* FATE THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND HIGHLIGHTS OPERATIONAL PROGRESS\n* Q1 REVENUE VIEW $1.7 MILLION â€” THOMSON REUTERS I/B/E/S * QTRLY LOSS PER SHARE $0.27 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T04:30:00.000+03:00",
    "crawled": "2018-05-11T12:46:05.004+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "fate",
        "therapeutic",
        "inc",
        "fate",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "highlight",
        "operational",
        "progress",
        "q1",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "qtrly",
        "loss",
        "per",
        "share",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}